Results 241 to 250 of about 46,788 (276)

Dia-B-Ties: B Cells in the Islet-Immune-Cell Interface in T1D. [PDF]

Biomolecules
Hilliard BK, Prendergast JE, Smith MJ.
europepmc   +1 more source

Six events that shaped antibody approvals in oncology. [PDF]

Front Immunol
Paul S, Zhou S.
europepmc   +1 more source

From Molecular Precision to Clinical Practice: A Comprehensive Review of Bispecific and Trispecific Antibodies in Hematologic Malignancies. [PDF]

Int J Mol Sci
Amoozgar B, Bangolo A, Habibi M, Cho C, Goy A.   +4 more
europepmc   +1 more source

Chimeric antigen receptor T-cell therapy remains effective after exposure to bispecific antibodies. Comment to "Sequencing of cellular therapy and bispecific antibodies for the management of diffuse large B-cell lymphoma". [PDF]

Haematologica
Crochet G, Houot R.
europepmc   +1 more source

Epstein-Barr Virus (EBV)-Positive Diffuse Large B-Cell Lymphoma in a Young Patient: A Difficult Diagnosis. [PDF]

Cureus
Kumagai M, Shimasaki M, Shioya A, Yamada S.   +3 more
europepmc   +1 more source

Multi-target drug discovery for rheumatoid arthritis: a comprehensive computational approach using bioactive compounds. [PDF]

Sci Rep
Mansouri P, Mansouri P, Najafipour S, Kouhpayeh SA, Farjadfar A, Behmard E.   +5 more
europepmc   +1 more source

Expansion of circulating T cells expressing low levels of the B cell-specific antigen CD20 (CD3 (+) CD20 (dim)) in patients with multiple myeloma.

, 2000
openaire   +2 more sources